Article Details
Retrieved on: 2021-03-18 12:22:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Monoclonal antibodies have been approved by federal regulators as a treatment for patients with mild to moderate symptoms of COVID-19. To help ...
Article found on: www.marketscreener.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here